Natural killer cell-mediated tumor cell lysis (non-MHC-restricted) (NK cell-mediated cytotoxicity)

Natural killer (NK) cell-mediated tumor lysis via non-MHC-restricted cytotoxicity" refers to the process by which NK cells recognize and kill tumor cells without the need for antigen presentation through major histocompatibility complex (MHC) molecules. Unlike T-cell mediated killing, which is MHC-restricted and requires specific antigen recognition, NK cells can detect target cells that have down-regulated MHC class I expression—a common feature of many tumors attempting to evade immune detection. This recognition occurs through a balance of activating and inhibitory signals received by various surface receptors on the NK cell. Activating receptors include natural cytotoxicity receptors such as NKp30, NKp44, and NKp46; these can sense stress-induced ligands or changes in heparan sulfate proteoglycans on tumor surfaces[3]. Additionally, antibody-dependent cellular cytotoxicity (ADCC) is a key mechanism where therapeutic antibodies like trastuzumab or cetuximab bind to antigens on tumor cells and engage FcγRIIIa/CD16A receptors on NK cells to trigger targeted killing[2]. This form of immune surveillance plays an important role in cancer immunology but is not itself a single molecular target; rather it describes an effector function involving multiple receptor-ligand interactions. Note: The entry "Tumor cell lysis via non-MHC-restricted cytotoxicity" does not refer to a specific molecule or receptor but rather describes an immunological process primarily mediated by natural killer cells. Therefore, it should not be considered a canonical therapeutic target molecule/receptor; instead, individual components such as "Natural killer cell activating receptor 1" (NKp46), "Fc gamma receptor IIIa", etc., would be appropriate targets for structured data extraction[2][3].

Other names

Non-MHC-restricted cytotoxicityNK cell cytotoxicityNatural killer cell anti-tumor activityNon-classical cytotoxic lymphocyte killing

Antibody-dependent cellular cytotoxicity (ADCC) via Fc receptor engagement[2]; Direct recognition of stress ligands or down-regulated MHC class I on tumor cells by activating receptors on NK cells[2][3]